Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.910
-0.200 (-4.87%)
Aug 26, 2026, 3:24 PM EDT - Market open
Opus Genetics Employees
As of December 31, 2025, Opus Genetics had 28 total employees, including 27 full-time and 1 part-time employees. The number of employees increased by 10 or 55.56% compared to the previous year.
Employees
28
Change (1Y)
10
Growth (1Y)
55.56%
Revenue / Employee
$352,000
Profits / Employee
-$3,843,214
Market Cap
325.30M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 28 | 10 | 55.56% | 27 | 1 |
| Dec 31, 2024 | 18 | 4 | 28.57% | 18 | 0 |
| Dec 31, 2023 | 14 | 5 | 55.56% | 14 | 0 |
| Dec 31, 2022 | 9 | 1 | 12.50% | 9 | 0 |
| Dec 31, 2021 | 8 | 3 | 60.00% | 8 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Abeona Therapeutics | 226 |
| ProQR Therapeutics | 187 |
| Sutro Biopharma | 128 |
| SAB Biotherapeutics | 86 |
| Orchestra BioMed Holdings | 86 |
| InflaRx | 65 |
| Immuneering | 57 |
IRD News
- 6 days ago - Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - Opus Genetics price target lowered to $9 from $10 at RBC Capital - TheFly
- 19 days ago - Opus Genetics Registration statement: Registration filing - Filings
- 19 days ago - Opus Genetics files $300M mixed securities shelf - TheFly
- 20 days ago - Opus Genetics reports Q2 EPS (14c), consensus (16c) - TheFly
- 20 days ago - Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update - GlobeNewsWire
- 20 days ago - Opus Genetics Earnings release: Q2 2026 - Filings
- 20 days ago - Opus Genetics Quarterly report: Q2 2026 - Filings